← Back to Search

Behavioral Intervention

cognitive rehabilitation group for Multiple Sclerosis

N/A

Waitlist Available

Research Sponsored by Sunnybrook Health Sciences Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

A define diagnosis of multiple sclerosis (which will include clinically isolate syndrome, radiologically isolated syndrome and neuromyelitis optica spectrum disorder)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 weeks immediate post assessment, and 6 months post assessment

Awards & highlights

Study Summary

This trial aims to improve the cognitive abilities of people with multiple sclerosis (MS) through a program called Goal Management Training (GMT). The study will have a treatment group that receives the GMT program and a

Who is the study for?

This trial is for individuals with Multiple Sclerosis who experience cognitive challenges, particularly in processing information, learning and memory, or executive function. Participants must be willing to undergo cognitive rehabilitation training.Check my eligibility

What is being tested?

The study tests Goal Management Training (GMT) as a form of cognitive rehabilitation for MS patients. It's a randomized controlled trial where the treatment group receives GMT sessions over 5 weeks and their progress is compared to a wait-list control group receiving usual care.See study design

What are the potential side effects?

Since the intervention involves non-invasive cognitive training exercises, no significant physical side effects are expected. However, participants may experience mental fatigue or frustration during the process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a form of multiple sclerosis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 weeks immediate post assessment, and 6 months post assessment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 weeks immediate post assessment, and 6 months post assessment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks immediate post assessment, and 6 months post assessment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants with improved Information processing speed

Secondary outcome measures

Number of participants with improved executive function

Number of participants with improved learning and memory

Other outcome measures

Number of participants with improved anxiety symptoms

Number of participants with improved depression symptoms

Number of people with improved fatigue symptoms

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: cognitive rehabilitation groupExperimental Treatment1 Intervention

will be treated by GMT for 5 weeks (two hour sessions per week, one day of rest in between).

Group II: wait-list control groupActive Control1 Intervention

will be given a list cognitive compensatory strategies that they can do on their own to improve their memory.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Goal Management Training

2017

N/A

~1160

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor

656 Previous Clinical Trials

1,551,258 Total Patients Enrolled

5 Trials studying Multiple Sclerosis

568 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for potential participants in this research study?

"The information provided on clinicaltrials.gov indicates that this particular study is not actively seeking participants. The trial was initially posted on January 2nd, 2024 and was last updated on December 11th, 2023. However, it's worth noting that there are currently 544 other studies actively recruiting participants."

Answered by AI

Is the age criterion for participation in this study inclusive of individuals who are 70 years old or older?

"To be considered eligible for this clinical trial, individuals must fall within the age range of 25 to 65. It is worth noting that there are a total of 36 studies specifically designed for participants under the age of 18 and an additional 400 studies catered towards patients over the age of 65."

Answered by AI

May I inquire about the criteria for potential participation in this medical study?

"Patients who meet the age criteria of being between 25 and 65 years old and have a diagnosis of multiple sclerosis are eligible to participate in this clinical trial. The study aims to recruit a total of 50 individuals."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Cognitive Rehabilitation for People With Multiple Sclerosis

Dr. Anthony Feinstein 2024. "Cognitive Rehabilitation for People With Multiple Sclerosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06179134.